Drug Profile
SIILPCV10
Alternative Names: 10-valent pneumococcal conjugate vaccine - Serum Institute of India; 10-valent pneumococcal vaccine conjugate - Serum Institute of India; Pneumococcal 10-valent vaccine conjugate - Serum Institute of India; PneumosilLatest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator PATH; Serum Institute of India
- Developer Primrose Bio; Serum Institute of India
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pneumococcal infections
Most Recent Events
- 18 Sep 2023 Primordial Genetics has merged with Pelican Expression Technology to form Primrose Bio
- 05 Jan 2023 Phase III development in Pneumococcal infections (Prevention, In volunteers, In infants) is still ongoing in Gambia (IM)
- 01 Dec 2021 Vabiotech plans a clinical trial for Pnemococcal infections (Prevention, In volunteers, In infants) (NCT05140720)